ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 644966 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 644966; 2) Community: the network communities that were significantly associated with the response to NSC 644966; 3) Molecule: the relationships between components within communities and NSC 644966; 4) MDR: the compounds that were significantly associated with the NSC 644966.

NSC Compound Enrichment Correlation
NSC 700583 [1,4,2,3]-Dithiaselenoca[5,6-d:7,8-d']diimidazole- 2,9-dithione, 1,3,8,10-tetrabutyl-1,2,3,8,9,10-hexahydro- 0.0141370771633662 -0.13848195
NSC 724706 Null 0.0141370771633662 0.29076104
NSC 730269 Null 0.0141370771633662 0.2515182
NSC 751548 Fluka catalog #46729 0.0141370771633662 0.1091183
NSC 732832 1-{2-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrol ylamino)phenylcarboxamido]ethyl}-3,4-dimethoxybenzene 0.0147237897640498 -0.10430561
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0147237897640499 0.66007148
NSC 313681 Oxiperomide(USAN) 0.0147237897640499 -0.032152826
NSC 328410 Camptothecin Derivative 0.0147237897640499 0.65439793
NSC 677586 Null 0.0147237897640499 -0.015039938
NSC 681632 Camptothecin Derivative 0.0147237897640499 0.59807185
Total:49  Current:12    [First] [Prev] [Next] [Last]